Presage Biosciences: Funding, Investors & Team (Oct 2026)
Presage has developed a means of assessing tumor response to drugs or RNA interference agents without the limitations inherent to systemic administration. The Presage clinical surrogate approach enables drug companies to halt development projects for compounds that show no efficacy in the native tumor microenvironment. In addition, the Presage approach can identify drug targets using RNA interference without concern regarding localization or distribution of systemically administered RNAi agents. Presage technology can also be used to identify effective drug combinations in ways that more directly measure the efficacy of such combinations than otherwise possible.
Presage Biosciences has raised $7.0M across 1 funding round on record, the most recent an undisclosed round of $7.0M announced in Mar 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Presage Biosciences Company Profile and Key Stats
Latest funding round on record: Mar 2021.
Presage Biosciences Funding Rounds
Presage Biosciences Founders and Leadership Team
Contact details for the Presage Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Presage Biosciences Funding Compared to Other Biotechnology Startups
Presage Biosciences' latest round of $7.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Presage Biosciences in Biotechnology and Seattle
Companies Similar to Presage Biosciences
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Presage Biosciences Funding FAQs
What does Presage Biosciences do?
Presage has developed a means of assessing tumor response to drugs or RNA interference agents without the limitations inherent to systemic administration. The Presage clinical surrogate approach enables drug companies to halt development projects for compounds that show no efficacy in the native tumor microenvironment. In addition, the Presage approach can identify drug targets using RNA interference without concern regarding localization or distribution of systemically administered RNAi agents. Presage technology can also be used to identify effective drug combinations in ways that more directly measure the efficacy of such combinations than otherwise possible.
How much funding has Presage Biosciences raised?
Presage Biosciences has raised $7.0M across 1 round on record. The most recent is an undisclosed round of $7.0M announced in Mar 2021.
When did Presage Biosciences last raise funding?
Presage Biosciences' most recent funding round on record is an undisclosed round of $7.0M, announced in Mar 2021.
Who is the CEO of Presage Biosciences?
Richard Klinghoffer is listed as CEO at Presage Biosciences.
Where is Presage Biosciences headquartered?
Presage Biosciences is based in Seattle, Washington, United States.
How many employees does Presage Biosciences have?
Presage Biosciences is in the 11-50 employee band.
How does Presage Biosciences' funding compare to other Biotechnology startups?
Presage Biosciences' latest round of $7.0M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Presage Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Presage Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.